Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLFS NASDAQ:ESTA NASDAQ:PLSE NASDAQ:SNWV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$25.91-0.8%$24.40$19.10▼$29.55$1.24B1.95469,775 shs285,649 shsESTAEstablishment Labs$42.23+3.5%$39.84$26.56▼$50.85$1.22B0.85490,377 shs176,464 shsPLSEPulse Biosciences$18.99+4.8%$15.94$13.77▼$25.00$1.28B1.79178,499 shs223,654 shsSNWVSanuwave Health$36.57-2.3%$37.75$5.63▼$46.58$313.41M1.3351,567 shs22,069 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+2.43%+8.38%+4.31%+12.34%+8.24%ESTAEstablishment Labs-0.41%-2.02%-1.09%-6.99%+0.64%PLSEPulse Biosciences+2.37%+2.55%+16.60%+22.47%+9.49%SNWVSanuwave Health-0.13%+4.20%-10.11%+18.26%+3,742,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLFSBioLife Solutions$25.91-0.8%$24.40$19.10▼$29.55$1.24B1.95469,775 shs285,649 shsESTAEstablishment Labs$42.23+3.5%$39.84$26.56▼$50.85$1.22B0.85490,377 shs176,464 shsPLSEPulse Biosciences$18.99+4.8%$15.94$13.77▼$25.00$1.28B1.79178,499 shs223,654 shsSNWVSanuwave Health$36.57-2.3%$37.75$5.63▼$46.58$313.41M1.3351,567 shs22,069 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLFSBioLife Solutions+2.43%+8.38%+4.31%+12.34%+8.24%ESTAEstablishment Labs-0.41%-2.02%-1.09%-6.99%+0.64%PLSEPulse Biosciences+2.37%+2.55%+16.60%+22.47%+9.49%SNWVSanuwave Health-0.13%+4.20%-10.11%+18.26%+3,742,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLFSBioLife Solutions 3.13Buy$31.2920.75% UpsideESTAEstablishment Labs 2.83Moderate Buy$56.5033.79% UpsidePLSEPulse Biosciences 3.00Buy$22.0015.85% UpsideSNWVSanuwave Health 3.33Buy$55.0050.40% UpsideCurrent Analyst Ratings BreakdownLatest SNWV, BLFS, PLSE, and ESTA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/3/2025SNWVSanuwave HealthNorthland CapmkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy9/3/2025SNWVSanuwave HealthNorthland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$55.008/22/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$54.00 ➝ $55.008/20/2025ESTAEstablishment LabsCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$60.008/11/2025BLFSBioLife SolutionsZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy8/8/2025BLFSBioLife SolutionsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$30.00 ➝ $32.007/29/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$49.007/22/2025BLFSBioLife SolutionsStephensSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOverweight$30.007/16/2025ESTAEstablishment LabsMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$58.00 ➝ $70.007/9/2025ESTAEstablishment LabsCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$38.00 ➝ $47.007/7/2025PLSEPulse BiosciencesOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$22.00(Data available from 10/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLFSBioLife Solutions$82.25M15.09$0.12 per share208.22$7.52 per share3.45ESTAEstablishment Labs$166.02M7.37N/AN/A$1.90 per share22.23PLSEPulse Biosciences$700K1,825.75N/AN/A$1.87 per share10.16SNWVSanuwave Health$32.63M9.60N/AN/A($1.49) per share-24.54Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLFSBioLife Solutions-$20.18M-$0.12N/AN/AN/A-5.39%0.16%0.14%11/11/2025 (Estimated)ESTAEstablishment Labs-$84.60M-$3.05N/AN/AN/A-49.89%-224.34%-25.53%11/6/2025 (Estimated)PLSEPulse Biosciences-$53.58M-$1.05N/A∞N/AN/A-63.19%-54.98%10/29/2025 (Estimated)SNWVSanuwave Health-$31.37M-$8.25N/A∞N/A-97.03%N/A-135.15%N/ALatest SNWV, BLFS, PLSE, and ESTA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/29/2025Q3 2025PLSEPulse Biosciences-$0.31N/AN/AN/A$0.50 millionN/A8/12/2025Q2 2025PLSEPulse Biosciences-$0.26-$0.28-$0.02-$0.28$0.50 millionN/A8/8/2025Q2 2025SNWVSanuwave Health-$0.09$0.01+$0.10$0.01$10.14 million$10.16 million8/7/2025Q2 2025BLFSBioLife Solutions-$0.02-$0.33-$0.31-$0.33$23.71 million$25.42 million8/7/2025Q2 2025ESTAEstablishment Labs-$0.54-$0.57-$0.03-$0.57$50.80 million$51.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLFSBioLife SolutionsN/AN/AN/AN/AN/AESTAEstablishment LabsN/AN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLFSBioLife SolutionsN/A4.433.45ESTAEstablishment Labs9.712.841.67PLSEPulse BiosciencesN/A12.0512.04SNWVSanuwave HealthN/A0.430.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLFSBioLife Solutions93.24%ESTAEstablishment Labs72.91%PLSEPulse Biosciences76.95%SNWVSanuwave Health42.53%Insider OwnershipCompanyInsider OwnershipBLFSBioLife Solutions2.20%ESTAEstablishment Labs11.09%PLSEPulse Biosciences74.60%SNWVSanuwave Health14.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLFSBioLife Solutions44047.90 million46.85 millionOptionableESTAEstablishment Labs1,01828.97 million25.76 millionOptionablePLSEPulse Biosciences14067.30 million17.09 millionOptionableSNWVSanuwave Health408.57 million7.29 millionN/ASNWV, BLFS, PLSE, and ESTA HeadlinesRecent News About These Companies3 Lesser-Known Healthcare Names With Major Upside in Store (SNWV)...October 2 at 8:18 AM | marketbeat.comFY2025 EPS Estimates for Sanuwave Health Raised by AnalystOctober 1 at 6:02 AM | marketbeat.comGoldman Sachs Group Inc. Makes New Investment in Sanuwave Health Inc. $SNWVSeptember 28, 2025 | marketbeat.comSanuwave Announces Strategic Debt Refinancing with New Credit FacilitySeptember 26, 2025 | globenewswire.comSanuwave Health (NASDAQ:SNWV) Cut to "Hold" at Wall Street ZenSeptember 21, 2025 | americanbankingnews.comSanuwave Health (NASDAQ:SNWV) Cut to Hold at Wall Street ZenSeptember 20, 2025 | marketbeat.comSanuwave: A Long-Term Compounder In Its Early StagesSeptember 15, 2025 | seekingalpha.comSanuwave Health (NASDAQ:SNWV) Downgraded to Buy Rating by Wall Street ZenSeptember 9, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Stock Rating Lowered by Wall Street ZenSeptember 9, 2025 | marketbeat.comNorthland Capmk Forecasts Sanuwave Health Q3 EarningsSeptember 7, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Upgraded to "Strong-Buy" at Northland CapmkSeptember 6, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Now Covered by Northland SecuritiesSeptember 5, 2025 | marketbeat.comAWM Investment Company Inc. Invests $18.15 Million in Sanuwave Health Inc. $SNWVSeptember 5, 2025 | marketbeat.comSolas Capital Management LLC Invests $20.66 Million in Sanuwave Health Inc. $SNWVSeptember 2, 2025 | marketbeat.comSANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comSanuwave (SNWV) Q2 Revenue Jumps 42%August 8, 2025 | fool.comSanuwave Announces Q2 FY2025 Financial ResultsAugust 8, 2025 | globenewswire.comSanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial ResultsAugust 4, 2025 | globenewswire.comSanuwave Health to Present at Canaccord Genuity Growth ConferenceJuly 22, 2025 | globenewswire.comSanuwave: High Growth Wound Care Tech Primed For A BreakoutJune 11, 2025 | seekingalpha.comSanuwave Health Appoints Industry Veteran Dustin Libby as Executive Vice President of Commercial OperationsJune 3, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSNWV, BLFS, PLSE, and ESTA Company DescriptionsBioLife Solutions NASDAQ:BLFS$25.91 -0.22 (-0.84%) Closing price 04:00 PM EasternExtended Trading$25.92 +0.02 (+0.06%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.BioLife Solutions, Inc. develops, manufactures, and markets bioproduction tools and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction tools, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; and the ThawSTAR line that comprises of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides cryogenic freezer technology for controlled rate freezing and cryogenic storage of biologic materials; ultra-low temperature mechanical freezers; evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage and transport services. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.Establishment Labs NASDAQ:ESTA$42.23 +1.41 (+3.45%) Closing price 04:00 PM EasternExtended Trading$41.98 -0.25 (-0.59%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.Pulse Biosciences NASDAQ:PLSE$18.99 +0.87 (+4.80%) Closing price 04:00 PM EasternExtended Trading$19.05 +0.06 (+0.29%) As of 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.Sanuwave Health NASDAQ:SNWV$36.57 -0.86 (-2.30%) As of 04:00 PM EasternSANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas How Berkshire's OxyChem Buy Cements Its Long-Term Strength NVIDIA Breaks Out to New Highs: What Comes Next? Down 22% From Highs, ServiceNow Could Be Too Cheap to Ignore Microsoft Stock Hits Stride in 2025—How Much More Can It Run? Datavault AI: The New AI Contender Backed by Big Funding Oklo Insiders Sell! Oh No! This Is Why Investors Shouldn’t Worry Rocket Lab's Electron: The Quiet Workhorse Powering Momentum CoreWeave: Why the New King of AI Infrastructure Has Room to Run Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
